Advanced

AJNR - American Journal of Neuroradiology

Publication Preview: Published September 3, 2008

American Journal of Neuroradiology 2009;30:428.

This Article Full Text (PDF) All Versions of this Article: ajnr.A1264v1 30/2/428    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Lin, F.Y. Articles by Kostakoglu, L. Search for Related Content PubMed PubMed Citation Articles by Lin, F.Y. Articles by Kostakoglu, L.

American Journal of Neuroradiology
DOI 10.3174/ajnr.A1264

HEAD & NECK

High Uptake in Schneiderian Papillomas of the Maxillary Sinus on Positron-Emission Tomography Using Fluorodeoxyglucose

F.Y. Lin, E.M. Genden, W.L. Lawson, P. Som and L. Kostakoglu

From the Department of Otolaryngology–Head and Neck Surgery (F.Y.L., E.M.G., W.L.L.), Head and Neck Cancer Center (E.M.G.), and Department of Radiology (P.S., L.K.), Mount Sinai School of Medicine, New York, NY.

Please address correspondence to Fred Y. Lin, MD, Department of Otolaryngology–Head and Neck Surgery, Mount Sinai School of Medicine, One Gustave L. Levy Pl, Box 1189, New York, NY 10029; e-mail: fred.lin{at}mssm.edu

SUMMARY: Schneiderian papillomas are benign tumors of the nasal cavity and paranasal sinuses often asymptomatic in their early stages. We report a case of a maxillary sinus oncocytic schneiderian papilloma first detected by positron-emission tomography by using fluorodeoxyglucose (FDG). Schneiderian papillomas demonstrate increased FDG uptake, similar to that of other oncocytic tumors, making it important for otolaryngologists and radiologists to realize that high uptake of FDG does not necessarily indicate a malignant lesion.